Takeda

1422 articles with Takeda

• Takeda Pharmaceutical Co. Ltd. Completes Subsequent Offering Period for Shares of Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts)

  5/14/2008

• Nektar Therapeutics's PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress

  5/12/2008

• Takeda Pharmaceutical Co. Ltd. Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) and Announces Subsequent Offering Period

  5/9/2008

• Abbott Laboratories, Takeda Pharmaceutical Co. Ltd. Conclude TAP Joint Venture

  5/1/2008

• FDA Approves AMITIZA(R) for the Treatment of Irritable Bowel Syndrome with Constipation in Adult Women; Medicine Marketed by Takeda Pharmaceutical Co. Ltd. and Its Developer, Sucampo Pharmaceuticals, Inc.

  4/30/2008

• Biotech Blossoms Anew

  4/30/2008

• Takeda Pharmaceutical Co. Ltd. and Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Announce Early Termination of Hart-Scott-Rodino Waiting Period

  4/29/2008

• Takeda Pharmaceutical Co. Ltd. New Data Published in Circulation Showed an Increase in HDL Cholesterol Levels with ACTOS(R) (pioglitazone HCl)

  4/16/2008

• Chemizon Inc. Announces a Second Expansion of Collaboration with Takeda Pharmaceutical Co. Ltd.

  4/16/2008

• Takeda Pharmaceutical Co. Ltd. Commences Cash Tender Offer for all Outstanding Shares of Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts)

  4/14/2008

• Affymax, Inc. and Takeda Pharmaceutical Co. Ltd. Report Long-Term Safety and Effectiveness Data of Hematide in Chronic Renal Failure Patients With Anemia

  4/4/2008

• Cell Genesys, Inc. to Webcast Conference Call to Discuss Global Alliance Formed With Takeda Pharmaceutical Co. Ltd. for the Development and Commercialization of GVAX Immunotherapy for Prostate Cancer

  4/1/2008

• BG Medicine Joins the HRP Initiative to Discover Biomarkers of High-Risk Atherosclerotic Plaque

  4/1/2008

• Takeda Pharmaceutical Co. Ltd. Says to Drop Development of Cholesterol Drug

  3/28/2008

• Takeda Pharmaceutical Co. Ltd. to Pay Abbott Laboratories up to $1.5B in Venture Split

  3/20/2008

• Takeda Pharmaceutical Co. Ltd. Announces New U.S. Leadership

  3/20/2008

• Takeda Pharmaceutical Co. Ltd. to Buy Abbott Laboratories Stake in U.S. Venture

  3/19/2008

• PPD, Inc. Confirms Takeda Pharmaceutical Co. Ltd.'s NDA Filing of Alogliptin with FDA; Triggers $15M Milestone Payment

  2/29/2008

• Merck KGaA, Takeda Pharmaceutical Co. Ltd. Cancel Development of Cancer Drug

  2/18/2008

• Affymax, Inc. Affirms Progress with Takeda Pharmaceutical Co. Ltd. Collaboration

  2/5/2008